-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Od9zoQ7R4XDPG2jMaJMbmCCoJMtSHZYEtWSjPoBCRZsm9cA+K7fqjqD6YRdwCURp /T8PeZ9e2uu9NCyGcGASSw== 0001443689-10-000009.txt : 20100308 0001443689-10-000009.hdr.sgml : 20100308 20100308090553 ACCESSION NUMBER: 0001443689-10-000009 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100308 DATE AS OF CHANGE: 20100308 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Chelsea Therapeutics International, Ltd. CENTRAL INDEX KEY: 0001333763 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203174202 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-81457 FILM NUMBER: 10662423 BUSINESS ADDRESS: STREET 1: 3530 TORINGDON WAY STREET 2: SUITE 200 CITY: CHARLOTTE STATE: NC ZIP: 28277 BUSINESS PHONE: 704-341-1516 MAIL ADDRESS: STREET 1: 3530 TORINGDON WAY STREET 2: SUITE 200 CITY: CHARLOTTE STATE: NC ZIP: 28277 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Senator Investment Group LP CENTRAL INDEX KEY: 0001443689 IRS NUMBER: 262124641 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 1330 AVENUE OF THE AMERICAS STREET 2: 26TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: (212) 376-4305 MAIL ADDRESS: STREET 1: 1330 AVENUE OF THE AMERICAS STREET 2: 26TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 SC 13G 1 chtp13gfile030810.txt SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------- Under the Securities Exchange Act of 1934 SCHEDULE 13G INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) CHELSEA THERAPEUTICS INTERNATIONAL, LTD. -------------------- (Name of Issuer) Common Stock, $.01 Par Value --------------------------------------- (Title of Class of Securities) 163428105 ------------ (CUSIP Number) February 26, 2010 ------------------------------------------------------ (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |_| Rule 13d-1(b) |X| Rule 13d-1(c) |_| Rule 13d-1(d) Page 1 of 6 Pages SCHEDULE 13G CUSIP No. 163428105 Page 2 of 6 Pages - ------------------------------------------------------------------------------- 1) NAME OF REPORTING PERSON SENATOR INVESTMENT GROUP LP - ------------------------------------------------------------------------------- 2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |X| - ------------------------------------------------------------------------------- 3) SEC USE ONLY - ------------------------------------------------------------------------------- 4) CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - ------------------------------------------------------------------------------- 5) SOLE VOTING POWER NUMBER 3,023,530 OF -------------------------------------------------- SHARES 6) SHARED VOTING POWER BENEFICIALLY OWNED BY 0 EACH -------------------------------------------------- REPORTING 7) SOLE DISPOSITIVE POWER PERSON WITH 3,023,530 -------------------------------------------------- 8) SHARED DISPOSITIVE POWER 0 - ------------------------------------------------------------------------------- 9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,023,530 - ------------------------------------------------------------------------------- 10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |_| - ------------------------------------------------------------------------------- 11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.52% - ------------------------------------------------------------------------------- 12) TYPE OF REPORTING PERSON IA - ------------------------------------------------------------------------------- Schedule 13G CUSIP No. 163428105 Page 3 of 6 Pages Item 1(a). Name of Issuer: CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Item 1(b). Address of Issuer's Principal Executive Offices: 3530 Toringdon Way, Suite 200 Charlotte, NC 28277 Item 2(a). Name of Persons Filing: Senator Investment Group LP Item 2(b). Address of Principal Business Office or, if None, Residence: The principal office of Senator Investment Group LP is: 1330 Avenue of the Americas 26th Floor New York, NY 10019 Item 2(c). Citizenship: Senator Investment Group LP is a Delaware limited partnership Item 2(d). Title of Class of Securities: Common Stock, $.01 Par Value Item 2(e). CUSIP Number: 163428105 Item 3. If this statement is filed pursuant to ss.ss. 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a: Not applicable Schedule 13G CUSIP No. 163428105 Page 4 of 6 Pages Item 4. Ownership. (a) Amount beneficially owned: 3,023,530 (b) Percent of class: 7.52%* (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 3,023,530 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 3,023,530 (iv) Shared power to dispose or to direct the disposition of: 0 Senator Investment Group LP, a Delaware limited partnership,serves as investment manager to a Delaware limited partnership, two Cayman Islands limited partnerships,and a Cayman Islands company (collectively, the "Funds"), and as such, has investment discretion with respect to the Funds. - -------------- * Percentages are based on 40,200,000 shares of common stock outstanding as of February 28, 2010 (35,000,406 shares of common stock as of October 30, 2009 plus 6,700,000 new shares issue pursuant to that placement agreement described in the Form 8-K filed with the Securities and Exchange Commission on February 26,2010). Schedule 13G CUSIP No. 163428105 Page 5 of 6 Pages Item 5. [ ] Ownership of Five Percent or Less of a Class. Not Applicable Item 6. Ownership of More than Five Percent on Behalf of Another Person. The partners of the Funds have the right to participate in the receipt of dividends from, or proceeds from the sale of, the securities reported herein held by the Funds in accordance with their respective ownership interests in the Funds. Senator Investment Group LP disclaims beneficial ownership of the securities included in this report and this report shall not be deemed an admission that Senator Investment Group LP is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect. Schedule 13G CUSIP No. 163428105 Page 6 of 6 Pages SIGNATURE ---------- After reasonable inquiry and to the best knowledge and belief of the undersigned, the undersigned certifies that the information set forth in this Statement is true, complete and correct. Dated as of March 8, 2010 Senator Investment Group LP By: Edward Larmann Chief Financial Officer By: /s/ Edward Larmann -------------------------------------- -----END PRIVACY-ENHANCED MESSAGE-----